Cytokinetics Inc (CYTK) support and resistance · rev $88.0M
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
This page maps Cytokinetics Inc (CYTK) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CYTK revenue for 2025-12-31 was $88.0M. Net income was -$785.0M. Revenue was up 376.6% from 2024-12-31 to 2025-12-31. CYTK currently screens at market cap $4.05B.
CYTK currently screens at market cap $4.05B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CYTK 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CYTK quote page for the session range and the stock page for the full model.
Not investment advice.